saascode
healthcare & clinical·run 293 · Jul 2026

Shelfsentry

A clinic formulary monitor that matches public recall, label and shortage records to locally reviewed medicines without collecting patient data.

Genesis score6.90/10
Make Shelfsentry real.0/500
500 more votes and Shelfsentry is authorized for build.
0%500 to authorize
Backing is the vote. When an idea crosses 500, we pull it into the build pipeline and ship it for real — the votes decide what gets built next, not an editor.
The case

Small clinics can subscribe to broad safety feeds yet still spend time deciding whether an alert reaches a drug, manufacturer, package or equivalent product they actually stock. Shelfsentry normalizes a clinic-approved formulary, preserves the exact public record and match path, and routes potentially relevant recalls, label changes, shortages and adverse-event count movements to a qualified reviewer. It does not diagnose risk, establish causation, prescribe a substitute, prove inventory, direct patient care or replace official notices and clinical judgment.

Who pays — and why

The pharmacy, medication-safety, clinical operations or practice-management owner at a small clinic that already reviews drug notices and maintains a local formulary.

What it unlocks
A daily queue limited to public records that may touch the clinic's reviewed formulary
Traceable drug-identifier matching with ambiguity and reviewer disposition
A correction history for formulary versions, public-source updates and prior notices
How Genesis scored it
6.90across seven criteria
tension 6temporal 7blindspot 5buyer 8leverage 8convergence 5why-not 8
8
Buyer persona

Clinic pharmacy, medication-safety and practice-operations owners have a concrete recurring notice-review job.

8
Asymmetric leverage

Public-source ingestion and matching are software-delivered and can serve many clinics with bounded marginal cost.

5
Convergence

The source records two cross-reference mentions, no inbound connection and three direct connections.

Why it scored well

Free public drug-data rails, a concrete small-clinic medication-safety buyer and a formulary-matching workflow make a focused self-serve wedge plausible.

What's holding it back

The source records no related signal, a thin and copyable technical moat, serious matching and clinical-governance risk, and no evidence that the proposed low-price segment will pay.

Signals detected4 sources crossed
SignalSupplied openFDA API review

SignalFDA query paging documentation review

SignalNational Library of Medicine RxNorm API documentation

SignalRecall-management competitor review

Direction briefshelfsentry.md
shelfsentry.md
Want this pointed at your vertical?Point Genesis at your own market and constraints — it invents adjacent, fork-ready ideas, private to you before they hit the public feed.

Discussion

?

No comments yet — be the first to weigh in.